Trial Profile
A Study Assessing the Safety and Effectiveness of Secukinumab for the Treatment of Plaque-Psoriasis in a Real-World Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2017 New trial record
- 07 Mar 2017 Trial design presented at the 75th Annual Meeting of the American Academy of Dermatology.